Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vidyanand Ravidas"'
Autor:
Shobha Kumari, Vikash Kumar, Ritesh Kumar Tiwari, Vidyanand Ravidas, Krishna Pandey, Ashish Kumar
Publikováno v:
Acta tropica. 235
Visceral leishmaniasis or Kala-azar is a vector-borne disease caused by an intracellular parasite of the genus leishmania. In India, Amphotericin B (AmB) is a first-line medication for treating leishmaniasis. After a large-scale resistance to pentava
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf989ccaa1d3070fccee8c0568eff00
https://pubmed.ncbi.nlm.nih.gov/35998680
https://pubmed.ncbi.nlm.nih.gov/35998680
Autor:
Anita Ambasta, Rakhi Kusumesh, Bibhuti Prassan Sinha, Lalan Kumar Arya, Vidyanand Ravidas, Nilesh Mohan
Publikováno v:
British Journal of Ophthalmology. 105:1497-1503
AimTo describe the characteristic clinical features and management of keratitis in the patients receiving miltefosine for post-kala-azar dermal leishmaniasis (PKDL).MethodsThe medical records of five patients with PKDL who presented with keratitis we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ba325df66481d9dad6907adb57c4e7c
https://doi.org/10.1136/bjophthalmol-2020-317325
https://doi.org/10.1136/bjophthalmol-2020-317325
Autor:
Krishna Pandey, A. C. Dhariwal, Vidyanand Ravidas, Tripurari P. Singh, R. B. Verma, R. K. Das Gupta, Pradeep Das, Sanjay Kumar Sinha, Niyamat Ali Siddiqui
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 95:1100-1105
Miltefosine, the only oral drug for visceral leishmaniasis (VL), is being used as the first-line drug under the VL elimination program in the Indian subcontinent. Miltefosine is an oral drug which was used as a topical application for skin metastasis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee49fbc31b3c60c69779a24e6a978f73
https://doi.org/10.4269/ajtmh.16-0242
https://doi.org/10.4269/ajtmh.16-0242
Autor:
Krishna Pandey, Neena Verma, Jaya Chakravarty, Shyam Sundar, Byron Arana, Poonam Kumari, Vidyanand Ravidas, Deepak Kumar Verma, H. W. Ghalib, Judith Berman, Shahnawaj Alam, Prabhat K. Sinha, N. Kumar
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 105(2)
The combination of one intravenous administration of 5mg/kg Ambisome and oral administration of miltefosine, 2.5mg/kg/day for 14 days, was evaluated in 135 Indian patients with kala-azar. The Intent-to-Treat cure rate at 6 months was 124 of the 135 e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e882e603220a3a7a9af8056f8adc69b
https://pubmed.ncbi.nlm.nih.gov/21129762
https://pubmed.ncbi.nlm.nih.gov/21129762